Herpes Zoster Virus Archives - Infectious Disease Advisor

General Infectious Disease

Shingrix Approved to Prevent Shingles in Immunocompromised Adults

By

Brian Park, PharmD

July 30, 2021

Previously, the vaccine was only approved for adults 50 years of age and older.

Pediatric Illnesses

Universal Vaccination Program Corresponds to Decrease in Overall Pediatric Herpes Zoster Cases

By

Bradley van Paridon

July 29, 2021

Investigators sought to assess the impact of age and vaccination status on rates of herpes zoster in a pediatric population.

General Infectious Disease

Herpes Simplex DNA Present in Corneal Tissues After Penetrating Keratoplasty

By

Jodi McCaffrey, MA, FACHE

July 16, 2021

Researchers support additional antiviral treatment following penetrating keratoplasty.

General Infectious Disease

Persistent Neurologic Sequelae Among Older Patients With Varicella-Zoster Virus CNS Infections

By

Jessica Nye, PhD

June 9, 2020

Investigators conducted an observational, retrospective study to assess variables associated with poor outcomes in patients with varicella-zoster virus infection with central nervous system involvement.

General Infectious Disease

ACTTION Partnership Publishes New Acute Neuropathic Pain Diagnostic Criteria

By

Lauren Biscaldi

May 4, 2021

The collaborative group believes that diagnostic criteria for acute neuropathic pain should provide a framework for research on and treatment of these complex pain conditions.

Risk of stroke after herpes zoster in patients with autoimmune diseases

General Infectious Disease

Herpes Zoster Vaccine Safe and Immunogenic in HSCT Recipients

By

Rita Aghjayan

April 21, 2021

Investigators conducted a study to determine the optimal vaccination timing and the temporal immunogenicity and safety of a live herpes zoster vaccine among patients post-HSCT.

Genitourinary

US Incidence Rates of Herpes Zoster and Postherpetic Neuralgia From 1994 to 2018

By

Bradley van Paridon

September 4, 2020

Researchers’ findings on the incidence rate of herpes zoster among unvaccinated age groups informs new set of recommendations.

Emerging Diseases

Chronic Fatigue Syndrome, Viruses, and the Innate Immune System

By

Theodore Henderson, MD, PhD

June 25, 2020

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.

Skin Infections

Varicella Strain Identity in First and Second Herpes Zoster Infection Episodes

By

Bradley van Paridon

December 16, 2019

Varicella zoster virus (VZV) is extremely stable during the varicella replication phase and subsequent establishment of latency in sensory ganglia throughout the body.

Prevention

Assessing Efficacy, Cost-Effectiveness of Herpes Zoster Vaccination

By

Madeline Morr

October 1, 2019

Researchers sought to compare the effectiveness and cost-savings of the recombinant subunit zoster vaccine with that of the live attenuated zoster vaccine in individuals aged ≥50 years.